Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Management
View:
Post by SleepyHoward on Jun 24, 2024 8:17am

Management

What the hell is going on.
Nobody answered in this f.......company. 
We need to know what is going on without money
Comment by forhandlaren on Jun 24, 2024 12:55pm
Reading the financial report you're absolutely right. But the reality is that the company does not run out of money, even though it should if we just read the financials.  I'm not worried. Go figure!
Comment by SleepyHoward on Jun 24, 2024 1:31pm
Why?
Comment by forhandlaren on Jun 24, 2024 2:36pm
Preparations for the product launch in Q1 2025 are well underway. Do you really think that the management would  just give up after so many years of R&D when the golden egg is due in seven months? I'm convinced that they will chip in themselves if neccessary. The alternative is just foolish.
Comment by tylerreddick on Jun 24, 2024 3:51pm
The only foolish ones are those of us who have put our hard-earned money on the line, ans watched the company feed us bs.
Comment by Turtle4 on Jun 25, 2024 2:52am
There will be no launch starting in 2025. They still want (need?) to carry out a study with the final formulation. The last one took a total of 5 months until the evaluation was published. So if the study doesn't start soon, it will be too late.   I think the company is now more or less shut down until some payment comes from allergan. Only then will it resume and that will determine ...more  
Comment by MirrorWorldMan on Jun 26, 2024 4:16pm
Not a bad plan. Give everyone a forced no pay vacation and hibernate , hoping AbbVie will launch. Do nothing with with the self proclaimed game changer molecules until money shows up.  Other the fumbling with the new agents will just dig a deeper hole. 
Comment by Turtle4 on Jun 24, 2024 2:28pm
And since many people do not believe this, we are at an all-time low
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities